Company Overview and News
(Reuters) - Ambuja Cements Ltd, part of the world's No.1 cement producer LafargeHolcim Ltd, posted an about 12 percent increase in quarterly consolidated net profit on Monday, boosted by higher cement sales volume.
European Dividend Growth Fund (the "Fund") has completed its initial public offering of 4.6 million units for total gross proceeds of $46 million. The units will commence trading today on the Toronto Stock Exchange under the symbol EDGF.UN.
European Dividend Growth Fund (the "Fund") has determined the exchange ratios for the exchange option (the "Exchange Option") with respect to its initial public offering. Under the Exchange Option, prospective purchasers could purchase units of the Fund by an exchange of freely tradable equity securities ("Exchange Securities") of the issuers listed in the table below (the "Exchange Eligible Issuers").
Brompton Funds Limited (the "Manager") is pleased to announce that European Dividend Growth Fund (the "Fund") has filed a final prospectus relating to the Fund's initial public offering of units with a maximum offering size of $150 million. The Fund is offering units at a price of $10.00 per unit. Closing is scheduled to occur on or about July 21, 2017.
Brompton Funds Limited (the "Manager") is pleased to announce that European Dividend Growth Fund (the "Fund") has filed a preliminary prospectus for the initial public offering of units of the Fund at a price of $10.00 per unit.
DUBLIN Building materials companies CRH (CRH.I) and LafargeHolcim (LHN.S) are contesting the final price of CRH's acquisition of assets from the Swiss-French company, the two companies said.
ZURICH (March 17): LafargeHolcim Ltd said demand at the world’s largest cement maker is expected to grow in 2016 even as a slowdown in some emerging market economies like Brazil and India led profit down last year.
LONDON, March 17 — European stocks rose with miners and energy shares after the Federal Reserve signaled a slower pace of rate increases, assuaging investor concern about tightening monetary policy hurting the global economy.
LafargeHolcim said 2015 results were affected by a slowing of economic growth in China as well as India. — Reuters picZURICH, March 17 — LafargeHolcim Ltd full-year profit was in line with estimates as the world’s largest cement maker said demand is expected to grow overall in 2016 even as a slowdown in some emerging market economies like India and Brazil hurt earnings last year.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...